355008-55-8

Basic information

• Product Name: 3-(2-Methylphenyl)-4-pyridinecarboxylicacidmethylester
• Synonyms: 3-(2-methylphenyl) isonicotinic acid, methyl ester
• CAS NO: 355008-55-8
• Molecular Formula: C₁₄H₁₃NO₂
• Molecular Weight: 0
• Mol File: 355008-55-8.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-(2-Methylphenyl)-4-pyridinecarboxylicacidmethylester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(2-Methylphenyl)-4-pyridinecarboxylicacidmethylester(355008-55-8)
• EPA Substance Registry System: 3-(2-Methylphenyl)-4-pyridinecarboxylicacidmethylester(355008-55-8)

Safety Data

• Hazardous Substances Data: 355008-55-8(Hazardous Substances Data)

Upstream product

• 16419-60-6 2-Methylphenylboronic acid 
• 188677-49-8 methyl 3-iodo-4-pyridinecarboxylate 
• 59786-31-1 methyl 3-bromoisonicotinate 
• 55279-30-6 methyl 3-aminoisonicotinate 
• 7579-20-6 3-Aminopyridine-4-carboxylic acid 

Downstream Products

• 355008-56-9 1-benzyl-3-(2-methylphenyl)-1,2,5,6-tetrahydroisonicotinic acid, methyl ester 
• 570397-03-4 4-(1-methoxycarbonyl-3-methylsulfanyl-propylcarbamoyl)-5-o-tolyl-3,6-dihydro-2H-pyridine-1-carboxylic acid 3-cyclohexyl-1-thiazol-5-yl-propyl ester 
• 355008-64-9 2-{[1-(benzyl-thiazol-5-ylmethyl-carbamoyl)-5-o-tolyl-1,2,3,6-tetrahydro-pyridine-4-carbonyl]-amino}-4-methylsulfanyl-butyric acid methyl ester 
• 355008-59-2 4-(1-methoxycarbonyl-3-methylsulfanyl-propylcarbamoyl)-5-o-tolyl-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 
• 355008-58-1 1-(1',1'-dimethylethoxycarbonyl)-3-(2-methylphenyl)-1,2,5,6-tetrahydroisonicotinic acid 

Relevant articles and documents

INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN

Compounds and compositions for modulating fibroblast activation protein (FAP) are described. The compounds and compositions may find use as therapeutic agents for the treatment of diseases, including hyperproliferative diseases.

Aryl tetrahydropyridine inhibitors of farnesyltransferase: Glycine, phenylalanine and histidine derivatives

Inhibitors of farnesyltransferase are effective against a variety of tumors in mouse models of cancer. Clinical trials to evaluate these agents in humans are ongoing. In our effort to develop new farnesyltransferase inhibitors, we have discovered a series of aryl tetrahydropyridines that incorporate substituted glycine, phenylalanine and histidine residues. The design, synthesis, SAR and biological properties of these compounds will be discussed.

Inhibitors of protein isoprenyl transferases

The present invention relates to novel compounds of Formula I which are useful in inhibiting protein isoprenyl transferases and the farnesylation or geranylgeranylation of the oncogene protein Ras and other related small g-proteins, and compositions containing such compounds and methods of using such compounds.